149
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

Low pregnancy-specific beta-1-glycoprotein is associated with nondipper hypertension and increased risk of preeclampsia in pregnant women with newly diagnosed chronic hypertension

ORCID Icon, , , , , , , & show all
Pages 479-488 | Received 21 Apr 2023, Accepted 20 Oct 2023, Published online: 27 Oct 2023

References

  • Tsakiridis I, Giouleka S, Arvanitaki A, et al. Chronic hypertension in pregnancy: synthesis of influential guidelines. J Perinat Med. 2021;49(7):859–872. doi: 10.1515/jpm-2021-0015.
  • Yoder SR, Thornburg LL, Bisognano JD. Hypertension in pregnancy and women of childbearing age. Am J Med. 2009;122(10):890–895. doi: 10.1016/j.amjmed.2009.03.036.
  • Bramham K, Parnell B, Nelson-Piercy C, et al. Chronic hypertension and pregnancy outcomes: systematic review and meta-analysis. BMJ. 2014;348(apr15 7):g2301–g2301. doi: 10.1136/bmj.g2301.
  • McCowan LM, Buist RG, North RA, et al. Perinatal morbidity in chronic hypertension. Br J Obstet Gynaecol. 1996;103(2):123–129. doi: 10.1111/j.1471-0528.1996.tb09662.x.
  • Agrawal A, Wenger NK. Hypertension during pregnancy. Curr Hypertens Rep. 2020;22(9):64. doi: 10.1007/s11906-020-01070-0.
  • Bramham K, Villa PM, Joslin JR, et al. Predisposition to superimposed preeclampsia in women with chronic hypertension: endothelial, renal, cardiac, and placental factors in a prospective longitudinal cohort. Hypertens Pregnancy. 2020;39(3):326–335. doi: 10.1080/10641955.2020.1769643.
  • Hermida RC, Ayala DE, Portaluppi F. Circadian variation of blood pressure: the basis for the chronotherapy of hypertension. Adv Drug Deliv Rev. 2007;59(9-10):904–922. doi: 10.1016/j.addr.2006.08.003.
  • Pickering TG. The clinical significance of diurnal blood pressure variations. Dippers and nondippers. Circulation. 1990;81(2):700–702. doi: 10.1161/01.cir.81.2.700.
  • Zweiker R, Eber B, Schumacher M, et al. Non-dipping related to cardiovascular events in essential hypertensive patients. Acta Med Austriaca. 1994;21:86–89.
  • Gavriilaki M, Anyfanti P, Nikolaidou B, et al. Nighttime dipping status and risk of cardiovascular events in patients with untreated hypertension: a systematic review and meta-analysis. J Clin Hypertens (Greenwich). 2020;22(11):1951–1959. doi: 10.1111/jch.14039.
  • Oney T, Meyer-Sabellek W. Variability of arterial blood pressure in normal and hypertensive pregnancy. J Hypertens Suppl. 1990;8: s 77–81.
  • Brown MA, Robinson A, Bowyer L, et al. Ambulatory blood pressure monitoring in pregnancy: what is normal? Am J Obstet Gynecol. 1998;178(4):836–842. doi: 10.1016/s0002-9378(98)70501-0.
  • Contard S, Chanudet X, Coisne D, et al. Ambulatory monitoring of blood pressure in normal pregnancy. Am J Hypertens. 1993;6(10):880–884. doi: 10.1093/ajh/6.10.880.
  • Hermida RC, Ayala DE, Mojón A, et al. Blood pressure patterns in normal pregnancy, gestational hypertension, and preeclampsia. Hypertension. 2000;36(2):149–158. doi: 10.1161/01.hyp.36.2.149.
  • Benedetto C, Zonca M, Marozio L, et al. Blood pressure patterns in normal pregnancy and in pregnancy-induced hypertension, preeclampsia, and chronic hypertension. Obstet Gynecol. 1996;88(4 Pt 1):503–510. doi: 10.1016/0029-7844(96)00217-7.
  • Ayala DE, Hermida RC, Mojón A, et al. Blood pressure variability during gestation in healthy and complicated pregnancies. Hypertension. 1997;30(3 Pt 2):611–618. doi: 10.1161/01.hyp.30.3.611.
  • Hermida RC, Ayala DE, Fernández JR, et al. Variación circadiana de la presión arterial en gestantes sanas, con hipertensión gestacional y con preeclampsia [circadian blood pressure variation in normal pregnancy, gestational hypertension, and preeclampsia]. Med Clin (Barc). 2003;120(14):521–528. doi: 10.1016/s0025-7753(03)73764-6.
  • Halligan A, Shennan A, Lambert PC, et al. Diurnal blood pressure difference in the assessment of preeclampsia. Obstet Gynecol. 1996;87(2):205–208. doi: 10.1016/0029-7844(95)00379-7.
  • Dwi Putra SE, Reichetzeder C, Meixner M, et al. DNA methylation of the glucocorticoid receptor gene promoter in the placenta is associated with blood pressure regulation in human pregnancy. J Hypertens. 2017;35(11):2276–2286. doi: 10.1097/HJH.0000000000001450.
  • Martell Claros N, Asenjo de la Fuente JE, Abad Cardiel M, et al. Papel del sistema renina-angiotensina en el embarazo y la preeclampsia [role of the renin-angiotensin system in pregnancy and preeclampsia]. Hipertens Riesgo Vasc. 2020;37(2):72–77. doi: 10.1016/j.hipert.2020.02.003.
  • Zhou GQ, Baranov V, Zimmermann W, et al. Highly specific monoclonal antibody demonstrates that pregnancy-specific glycoprotein (PSG) is limited to syncytiotrophoblast in human early and term placenta. Placenta. 1997;18(7):491–501. doi: 10.1016/0143-4004(77)90002-9.
  • Pluta M, Hardt W, Schmidt-Gollwitzer K, et al. Radioimmunoassay of serum SP 1 and HPL in normal and abnormal pregnancies. Arch Gynecol. 1979;227(4):327–336. doi: 10.1007/BF02109921.
  • Temur M, Serpim G, Tuzluoğlu S, et al. Comparison of serum human pregnancy-specific beta-1-glycoprotein 1 levels in pregnant women with or without preeclampsia. J Obstet Gynaecol. 2020;40(8):1074–1078. doi: 10.1080/01443615.2019.1679734.
  • Snyder SK, Wessner DH, Wessells JL, et al. Pregnancy-specific glycoproteins function as immunomodulators by inducing secretion of IL-10, IL-6 and TGF-beta1 by human monocytes. Am J Reprod Immunol. 2001;45(4):205–216. doi: 10.1111/j.8755-8920.2001.450403.x.
  • Rodriguez-Iturbe B, Pons H, Johnson RJ. Role of the ımmune system in hypertension. Physiol Rev. 2017;97(3):1127–1164. doi: 10.1152/physrev.00031.2016.
  • Moore T, Williams JM, Becerra-Rodriguez MA, et al. Pregnancy-specific glycoproteins: evolution, expression, functions and disease associations. Reproduction. 2022;163(2):R11–R23. doi: 10.1530/REP-21-0390.
  • Brown MA, Magee LA, Kenny LC, International Society for the Study of Hypertension in Pregnancy (ISSHP)., et al. The hypertensive disorders of pregnancy: ISSHP classification, diagnosis & management recommendations for international practice. Pregnancy Hypertens. 2018;13:291–310. doi: 10.1016/j.preghy.2018.05.004.
  • Guedes-Martins L. Chronic hypertension and pregnancy. Adv Exp Med Biol. 2017;956:395–407.
  • Rana S, Lemoine E, Granger JP, et al. Preeclampsia: pathophysiology, challenges, and perspectives. Circ Res. 2019;124(7):1094–1112. doi: 10.1161/CIRCRESAHA.118.313276.
  • Mutter WP, Karumanchi SA. Molecular mechanisms of preeclampsia. Microvasc Res. 2008;75(1):1–8. doi: 10.1016/j.mvr.2007.04.009.
  • Baumwell S, Karumanchi SA. Pre-eclampsia: clinical manifestations and molecular mechanisms. Nephron Clin Pract. 2007;106(2):c72–c81. doi: 10.1159/000101801.
  • Bersinger NA, Ødegård RA. Second- and third-trimester serum levels of placental proteins in preeclampsia and small-for-gestational age pregnancies. Acta Obstet Gynecol Scand. 2004;83(1):37–45. doi: 10.1111/j.1600-0412.2004.00277.x.
  • Streydio C, Swillens S, Georges M, et al. Structure, evolution and chromosomal localization of the human pregnancy-specific beta 1 glycoprotein gene family. Genomics. 1990;6(4):579–592. doi: 10.1016/0888-7543(90)90492-d.
  • Chapman MG, O'Shea RT, Jones WR, et al. Pregnancy-specific beta 1-glycoprotein as a screening test for at-risk pregnancies. Am J Obstet Gynecol. 1981;141(5):499–502. doi: 10.1016/s0002-9378(15)33268-3.
  • Ho PC, Jones WR. Pregnancy-specific beta 1-glycoprotein as a prognostic indicator in complications of early pregnancy. Am J Obstet Gynecol. 1980;138(3):253–256. doi: 10.1016/0002-9378(80)90243-4.
  • Tuzluoğlu S, Üstünyurt E, Karaşin SS, et al. Investigation of serum Pregnancy-Specific beta-1-Glycoprotein and relationship with fetal growth restriction. JBRA Assist Reprod. 2022;26:267–273.
  • Heerkens EH, Izzard AS, Heagerty AM. Integrins, vascular remodeling, and hypertension. Hypertension. 2007;49(1):1–4. doi: 10.1161/01.HYP.0000252753.63224.3b.
  • Rattila S, Dunk CEE, Im M, et al. Interaction of Pregnancy-Specific glycoprotein 1 With ıntegrin Α5β1 Is a modulator of extravillous trophoblast functions. Cells. 2019;8(11):1369. doi: 10.3390/cells8111369.
  • Ankumah NE, Sibai BM. Chronic hypertension in pregnancy: diagnosis, management, and outcomes. Clin Obstet Gynecol. 2017;60(1):206–214. doi: 10.1097/GRF.0000000000000255.
  • Bouchlariotou S, Liakopoulos V, Dovas S, et al. Nocturnal hypertension is associated with an exacerbation of the endothelial damage in preeclampsia. Am J Nephrol. 2008;28(3):424–430. doi: 10.1159/000112807.
  • Hu Z, Li G, Wang JW, et al. Regulation of blood pressure by targeting CaV1.2-Galectin-1 protein ınteraction. Circulation. 2018;138(14):1431–1445. doi: 10.1161/CIRCULATIONAHA.117.031231.
  • Hirashima C, Ohkuchi A, Nagayama S, et al. Galectin-1 as a novel risk factor for both gestational hypertension and preeclampsia, specifically its expression at a low level in the second trimester and a high level after onset. Hypertens Res. 2018;41(1):45–52. doi: 10.1038/hr.2017.85.
  • Bouchlariotou S, Liakopoulos V, Giannopoulou M, et al. Melatonin secretion is impaired in women with preeclampsia and an abnormal circadian blood pressure rhythm. Ren Fail. 2014;36(7):1001–1007. doi: 10.3109/0886022X.2014.926216.
  • Stennett AK, Khalil RA. Neurovascular mechanisms of hypertension in pregnancy. Curr Neurovasc Res. 2006;3(2):131–148. doi: 10.2174/156720206776875885.
  • Mendoza M, Lu D, Ballesteros A, et al. Glycan characterization of pregnancy-specific glycoprotein 1 and its identification as a novel galectin-1 ligand. Glycobiology. 2020;30(11):895–909. doi: 10.1093/glycob/cwaa034.
  • Ha CT, Wu JA, Irmak S, et al. Human pregnancy specific beta-1-glycoprotein 1 (PSG1) has a potential role in placental vascular morphogenesis. Biol Reprod. 2010;83(1):27–35. doi: 10.1095/biolreprod.109.082412.
  • Aggarwal R, Jain AK, Mittal P, et al. Association of pro- and anti-inflammatory cytokines in preeclampsia. J Clin Lab Anal. 2019;33:e22834.
  • Abalos E, Duley L, Steyn DW, et al. Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev. 2018;10: CD002252.
  • Rolnik DL, Nicolaides KH, Poon LC. Prevention of preeclampsia with aspirin. Am J Obstet Gynecol. 2022;226(2S):S1108–S1119. doi: 10.1016/j.ajog.2020.08.045.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.